Literature DB >> 16635666

Hyperimmunoglobulin E syndrome: two cases and a review of the literature.

Christine A DeWitt1, Amanda B Bishop, Lucinda S Buescher, Stephen P Stone.   

Abstract

Hyperimmunoglobulin E syndrome (HIES) is a rare immunodeficiency associated with elevated serum IgE levels, eczematous skin, recurrent cutaneous infections, and distinctive musculoskeletal features. We report two cases seen at our institution and review the current literature. Patient 1 was an 18-month-old African American boy with recurrent staphylococcal cold abscesses, pneumonia, and bacteremia. He had severely eczematous skin, ultimately complicated by eczema herpeticum. After treatment of systemic infections with culture-directed antibiotics, a brief course of cyclosporine, 5 mg/kg, improved the dermatitis and allowed transition to long-term therapy with oral trimethoprim-sulfamethoxazole. Patient 2 was a 15-year-old Caucasian boy with long-standing HIES. He has been maintained on a regimen of interferon gamma injections given 3 times weekly and monthly intravenous immunoglobulin since the age of 3 years, prophylactic antibiotics, and low-dose fluconazole. He has occasional episodes of cold abscesses and sinusitis, but has had excellent control since institution of this regimen and has not experienced any adverse effects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16635666     DOI: 10.1016/j.jaad.2005.10.022

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  11 in total

1.  Recurrent giant chalazia in hyperimmunoglobulin E (Job's) syndrome.

Authors:  Pierpaolo Patteri; Alain Serru; Maria Letizia Chessa; Michele Loi; Antonio Pinna
Journal:  Int Ophthalmol       Date:  2008-06-05       Impact factor: 2.031

2.  Hyperimmunoglobulin E syndrome (Job syndrome): chest CT findings.

Authors:  Pablo Rydz Pinheiro Santana; Augusto Kreling Medeiros; Cinthia Callegari Barbisan; Antônio Carlos Portugal Gomes; Edson Marchiori
Journal:  J Bras Pneumol       Date:  2018 Jul-Aug       Impact factor: 2.624

Review 3.  Evidence for the use of intravenous immunoglobulins--a review of the literature.

Authors:  Shaye Kivity; Uriel Katz; Natalie Daniel; Udi Nussinovitch; Neophytos Papageorgiou; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

Review 4.  Clinical immunology review series: an approach to the patient with recurrent superficial abscesses.

Authors:  S L Johnston
Journal:  Clin Exp Immunol       Date:  2008-04-16       Impact factor: 4.330

Review 5.  [Eosinophilic dermatoses].

Authors:  G Wozel
Journal:  Hautarzt       Date:  2007-04       Impact factor: 0.751

6.  An Unusual Pattern of Premature Cervical Spine Degeneration in STAT3-LOF.

Authors:  Amelia L Mitchell; Amanda K Urban; Alexandra F Freeman; Dima A Hammoud
Journal:  J Clin Immunol       Date:  2021-01-06       Impact factor: 8.317

Review 7.  The hyperimmunoglobulin E syndrome--clinical manifestation diversity in primary immune deficiency.

Authors:  Aleksandra Szczawinska-Poplonyk; Zdzislawa Kycler; Barbara Pietrucha; Edyta Heropolitanska-Pliszka; Anna Breborowicz; Karolina Gerreth
Journal:  Orphanet J Rare Dis       Date:  2011-11-15       Impact factor: 4.123

8.  Hyperimmunoglobulin E syndrome in two siblings.

Authors:  Abdulmohti Hawilo; Inès Zaraa; Sondes Trojjet; Hella Zribi; Rym Cheikh Rouhou; Dalenda El Euch; Mourad Mokni; Amel Ben Osman
Journal:  Dermatol Reports       Date:  2011-11-28

9.  Hyper Ig E syndrome (Job syndrome, HIES) - radiological images of pulmonary complications on the basis of three cases.

Authors:  Katarzyna Jończyk-Potoczna; Aleksandra Szczawińska-Popłonyk; Małgorzata Warzywoda; Anna Bręborowicz; Bogdan Pawlak
Journal:  Pol J Radiol       Date:  2012-04

10.  Hyperimmunoglobulin E syndrome with persistent vertebral osteomyelitis due to methicillin-resistant Staphylococcus aureus: Case report and review of the literature.

Authors:  San S Wong; Peter R Smith; Asim Ayaz; Douglas Sepkowitz
Journal:  IDCases       Date:  2014-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.